Anika Therapeutics, Inc. Financial Ratios — ANIK Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	28.08	29.2	36.46	44.61	25.54	21.4	17.29	8.96	11.72	-10.27	1.85	-6.81	-48.76	-56.38	-16.39
Return on Assets (%)	6.47	8.55	13.8	21.97	14.35	13.68	12.17	6.67	8.92	-6.89	1.16	-4.27	-26.68	-23.82	-5.54
Return on Capital (%)	20.08	23.2	33.6	44.61	25.54	21.4	17.29	8.96	11.18	- -	- -	-6.08	-41.57	- -	- -
Return on Invested Capital (%)	8.41	11.85	16.01	24.4	15.62	14.8	13.01	6.7	9.01	- -	- -	0.6	-0.33	- -	- -
Gross Margin (%)	58.65	59.38	69.68	80.18	77.36	76.76	75.87	70.37	74.92	52.91	56.12	64.33	68.33	63.38	56.56
EBITDA Margin (%)	27.74	37.53	49.4	62.65	55.82	52.56	44.1	26.2	35.11	-0.77	-2.82	15.95	12.47	2.52	-4.72
Operating Margin (%)	21.56	31.19	43.05	58.19	51.76	48.95	40.32	20.6	29.88	-11.09	-12.5	3.22	0.7	-4.25	-9.8
Incremental Operating Margin (%)	69.72	125.93	270.43	95.45	105.69	23.82	-48.58	304.9	138.03	- -	- -	-65.21	-40.57	- -	- -
Pretax Margin (%)	21.28	27.37	43.26	58.25	51.89	49.21	40.74	21.99	31.52	-21.94	1.64	3.8	2.61	-2.31	-8.25
Profit Margin (%)	13.07	16.48	27.4	36.29	33.07	31.48	28.05	17.74	23.73	-18.38	2.8	-13.05	-68.44	-47.02	-9.64
Net Income to Common Margin (%)	13.07	16.48	27.4	36.29	33.07	31.48	28.05	17.74	23.73	-18.38	2.8	-13.05	-68.44	-47.02	-9.64
Effective Tax Rate (%)	38.58	39.79	36.65	37.7	36.26	36.02	31.14	19.33	24.72	- -	- -	49.12	208.97	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	28.08	29.2	36.46	44.61	25.54	21.4	17.29	8.96	11.72	-10.27	1.85	-6.81	-48.76	-56.38	-16.39

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	11	10	- -	- -	- -	- -	- -	- -	23	22	21	31	28	26	26
ST Debt	2	2	- -	- -	- -	- -	- -	- -	1	2	2	2	2	2	2
LT Debt	10	8	- -	- -	- -	- -	- -	- -	21	21	19	29	26	24	24
Total Debt/EBITDA	0.62	0.36	- -	- -	- -	- -	- -	- -	0.56	-22.37	-5.03	1.7	1.84	8.59	-4.93
Net Debt/EBITDA	-1.37	-1.29	-1.71	-1.51	-2.13	-1.92	-2.66	-3.22	-3.91	95.44	22.67	-4.75	-4.56	-18.42	10.8
Total Debt/EBIT	0.8	0.43	- -	- -	- -	- -	- -	- -	0.66	-1.55	-1.13	8.42	32.87	-5.08	-2.38
Net Debt/EBIT	-1.76	-1.55	-1.96	-1.63	-2.3	-2.06	-2.91	-4.09	-4.6	6.62	5.11	-23.52	-81.45	10.91	5.2
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	25.89	32.48	42.76	54.49	57.61	70.08	70.65	78.27	74.26	60.61	64.95	60.4	47.37	35.42	32.02
Long-Term Debt/Equity (%)	10.13	7.34	- -	- -	- -	- -	- -	- -	7.41	7.66	6.7	10.09	12.21	15.59	16.87
Long-Term Debt/Capital (%)	21.06	14.35	- -	- -	- -	- -	- -	- -	7.97	8.56	7.8	11.92	16.62	24.57	27.76
Long-Term Debt/Total Assets (%)	7.23	5.63	- -	- -	- -	- -	- -	- -	6.46	5.71	5.54	8.25	9.58	11.84	12.72
Total Debt/Equity (%)	11.82	8.81	- -	- -	- -	- -	- -	- -	7.81	8.25	7.3	10.82	13.07	16.84	18.3
Total Debt/Capital (%)	24.57	17.22	- -	- -	- -	- -	- -	- -	8.4	9.2	8.49	12.78	17.79	26.53	30.11
Total Debt/Total Assets (%)	8.43	6.76	- -	- -	- -	- -	- -	- -	6.81	6.14	6.03	8.85	10.25	12.79	13.8
Net Debt to Equity	-25.94	-31.64	-46.69	-56.24	-52.51	-46.8	-50.57	-33.78	-54.6	-35.18	-32.88	-30.23	-32.38	-36.13	-40.07
Net Debt/Capital (%)	-250.5	-295.08	-1,866.07	-2,045.25	-440.98	-162.67	-200.68	-68.85	-142.35	-64.64	-61.98	-55.54	-78.83	-132.09	-193.58
EBITDA	18	27	37	66	52	54	50	28	40	-1	-4	18	15	3	-5
EBITDA-CapEx	17	25	37	65	43	40	41	23	37	-3	-9	11	10	-5	-12
Operating Income (Loss)	14	22	32	61	48	51	46	22	34	-14	-18	4	1	-5	-11

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.46	3.05	6.82	17.9	8.01	14.18	12.03	14.09	11.36	2.67	3.17	3.09	2.21	2.39	2.62
Current Ratio	4.41	5.35	10.19	23.08	10.21	19.37	15.78	17.98	14.39	4.81	5.66	6.07	5.26	4.88	4.72
Quick Ratio	3.65	4.53	8.84	20.77	9.27	17.32	13.85	15.93	12.78	3.32	4.17	4.33	3.06	3.4	3.71
CFO/Avg Current Liab	0.6	0.73	2.12	5.24	3.43	1.88	3.73	2.87	2.68	0.49	0.25	0.15	-0.06	0.2	0.49
Common Equity/Total Assets	25.89	32.48	42.76	54.49	57.61	70.08	70.65	78.27	74.26	60.61	64.95	60.4	47.37	35.42	32.02
Long-Term Debt/Equity (%)	10.13	7.34	- -	- -	- -	- -	- -	- -	7.41	7.66	6.7	10.09	12.21	15.59	16.87
Long-Term Debt/Capital (%)	21.06	14.35	- -	- -	- -	- -	- -	- -	7.97	8.56	7.8	11.92	16.62	24.57	27.76
Long-Term Debt/Total Assets (%)	7.23	5.63	- -	- -	- -	- -	- -	- -	6.46	5.71	5.54	8.25	9.58	11.84	12.72
Total Debt/Equity (%)	11.82	8.81	- -	- -	- -	- -	- -	- -	7.81	8.25	7.3	10.82	13.07	16.84	18.3
Total Debt/Capital (%)	24.57	17.22	- -	- -	- -	- -	- -	- -	8.4	9.2	8.49	12.78	17.79	26.53	30.11
Total Debt/Total Assets (%)	8.43	6.76	- -	- -	- -	- -	- -	- -	6.81	6.14	6.03	8.85	10.25	12.79	13.8
CFO/Total Liabilities	26.71	31.83	123.31	271.77	160.29	139.92	213.38	227.02	87.42	14.02	13.89	6.94	-3.06	11.08	23.9
CFO/CapEx	7.26	7.01	57.06	25.74	4.33	1.74	4.54	7.5	13.09	8.03	1.63	0.59	-0.33	0.65	1.64
Altman's Z-Score	4.18	4.91	18.76	28.01	16.65	27.82	27.59	21.66	13.02	6.25	7.33	6.28	5.19	4.6	3.2

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.03	3.68	3.74	5.88	4.79	4.2	4.41	4.73	5.23	5.53	5.48	3.53	3.96	4.8	4.77
Days Sales Outstanding	90.51	99.16	97.71	62.03	76.15	86.94	82.74	77.11	69.83	66	66.61	103.37	92.14	76.03	76.49
Inventory Turnover	3.3	3.72	2.36	1.79	1.54	1.55	1.44	1.44	1.33	1.8	1.58	1.07	1.19	1.82	2.3
Days Inventory Outstanding	110.74	98.12	154.56	204.07	237.04	234.86	253.56	252.83	274.86	202.62	231.38	340.56	306.2	200.49	158.61
Accounts Payable Turnover	3.59	9.02	9.92	11.18	4.96	4.73	7.38	6.18	8.44	13.37	6.58	5.31	3	7.33	7.55
Accounts Payable Turnover Days	101.6	40.44	36.79	32.63	73.54	77.19	49.43	59.09	43.24	27.31	55.49	68.73	121.56	49.79	48.37
Cash Conversion Cycle	99.65	156.83	215.49	233.46	239.65	244.61	286.87	270.85	301.45	241.31	242.5	375.19	276.79	226.73	186.73
Inventory to Cash Days	-20.23	1.03	-56.85	-142.04	-160.89	-147.92	-170.81	-175.72	-205.03	-136.62	-164.76	-237.19	-214.06	-124.46	-82.12
Inventories	7	8	11	12	15	16	22	21	22	46	36	40	24	24	19
Raw Materials	4	6	6	6	6	6	11	14	12	15	17	21	- -	- -	- -
Work In Process	2	1	2	3	6	6	6	5	8	13	11	11	- -	- -	- -
Finished Goods	2	1	3	3	4	5	5	7	9	33	27	25	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	-4	-7	-15	-19	-17	24	24	19

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	128	132	538	598	570	719	786	485	732	644	516	431	332	242	138
- Cash & Cash Equivalents	36	44	63	100	111	104	133	89	157	96	94	86	69	56	57
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	11	10	- -	- -	- -	- -	- -	- -	23	22	21	31	28	26	26
Enterprise Value	103	97	474	491	431	594	628	326	570	568	443	376	291	213	107
Total Capital	46	56	67	105	136	168	200	218	268	244	247	242	156	98	87
Total Debt/Capital (%)	24.57	17.22	- -	- -	- -	- -	- -	- -	8.4	9.2	8.49	12.78	17.79	26.53	30.11
Total Debt / EV	0.11	0.1	- -	- -	- -	- -	- -	- -	0.04	0.04	0.05	0.08	0.1	0.12	0.25
EV/Sales	1.6	1.36	6.32	4.65	4.64	5.75	5.54	3.09	4.97	4.35	2.99	3.3	2.41	1.77	0.94
EV/EBITDA	5.76	3.64	12.79	7.42	8.31	10.93	12.56	11.8	14.16	- -	- -	20.68	19.33	70.41	- -
EV/EBIT	7.41	4.37	14.67	7.99	8.96	11.74	13.74	15.01	16.64	- -	- -	102.33	344.91	- -	- -
EV/Cash Flow to Firm	10.17	9.23	18.84	12.28	10.81	24.3	15.4	9.35	15.4	43.46	52.7	85.18	- -	39.35	9.52
EV/Free Cash Flow to Firm	8.94	8.08	18.52	11.82	8.78	15.45	12.62	8.25	14.3	38.65	32.69	31.57	80	15.48	5.92
Diluted Market Cap	135	143	566	622	585	740	812	494	745	644	524	431	332	242	138
Diluted Enterprise Value	110	108	502	522	474	636	679	405	610	570	451	376	291	213	107
EV per Share	7.92	7.34	33.66	33.46	28.89	40.46	43.12	22.6	40.35	39.93	30.73	25.79	19.86	14.44	7.43
TTM Sales	65	71	75	106	93	103	113	106	115	130	148	114	121	120	113
TTM EBITDA	18	27	37	66	52	54	50	28	40	-1	-4	18	15	3	-5
TTM Operating Income	14	22	32	61	48	51	46	22	34	-14	-18	4	1	-5	-11
TTM Cash Flow to Firm	10	11	25	40	40	24	41	35	37	13	8	4	-2	5	11
TTM Free Cash Flow to Firm	12	12	26	42	49	38	50	40	40	15	14	12	4	14	18

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	11.64	11.83	22.09	14.98	11.9	19.24	16.31	12.48	18.71	43.81	38.72	36.23	91.26	17.64	7.65
EV/EBIT	7.41	4.37	14.67	7.99	8.96	11.74	13.74	15.01	16.64	- -	- -	102.33	344.91	- -	- -
Enterprise Value	103	97	474	491	431	594	628	326	570	568	443	376	291	213	107
Low Price	5.24	9	10	28.79	30.93	35.07	41.64	28.54	29.01	22.01	32.3	19.95	16.54	15.83	7.87
EV/Sales	1.6	1.36	6.32	4.65	4.64	5.75	5.54	3.09	4.97	4.35	2.99	3.3	2.41	1.77	0.94
EV/EBITDA	5.76	3.64	12.79	7.42	8.31	10.93	12.56	11.8	14.16	- -	- -	20.68	19.33	70.41	- -
Price/Earnings	15.12	11.21	26.13	15.61	18.53	22.09	24.7	25.93	26.93	- -	124.82	- -	- -	- -	- -
Price/Earnings Average	11.62	14.33	13.7	15.71	18.1	20.7	23.07	33.33	23.47	-21.86	140.93	-25.53	-4.34	-6.25	-15.84
Price/Earnings High	18.01	19.96	26.48	20.11	22.02	24.79	27.62	53.85	39.32	-32.68	168.5	-36.11	-5.73	-7.6	-24.21
Price/Earnings Low	8.09	10.15	6.85	11.03	15.02	15.82	19.08	22.02	15.06	-13.05	112.52	-19.55	-2.93	-4.13	-10.37
Price/Book Value	3.72	2.86	8.06	5.69	4.2	4.27	3.94	2.22	2.98	2.9	2.29	2.04	2.59	3.37	2.26
Price/Book Value Average	2.86	3.65	4.22	5.73	4.1	4	3.68	2.86	2.6	2.37	2.58	1.8	2.8	4.91	2.83
Price/Book Value High	4.43	5.09	8.17	7.33	4.99	4.79	4.4	4.62	4.35	3.54	3.09	2.54	3.7	5.97	4.32
Price/Book Value Low	1.99	2.59	2.11	4.02	3.4	3.06	3.04	1.89	1.67	1.41	2.06	1.38	1.89	3.25	1.85
Price/Tangible Book Value	2.04	1.66	5.01	3.86	2.97	3.5	3.21	1.97	2.68	3.72	2.62	2.12	1.64	1.68	1.03
Price/Tangible Book Value Average	1.57	2.12	2.63	3.89	2.9	3.28	3	2.53	2.34	3.03	2.96	1.86	1.77	2.44	1.29
Price/Tangible Book Value High	2.43	2.95	5.08	4.98	3.53	3.93	3.59	4.09	3.91	4.53	3.54	2.63	2.34	2.97	1.97
Price/Tangible Book Value Low	1.09	1.5	1.31	2.73	2.41	2.51	2.48	1.67	1.5	1.81	2.36	1.43	1.2	1.61	0.84
Price/Sales	1.98	1.85	7.16	5.66	6.13	6.95	6.93	4.6	6.39	4.93	3.49	3.79	2.75	2.02	1.22
Price/Sales Average	1.52	2.36	3.75	5.7	5.99	6.52	6.47	5.91	5.57	4.02	3.94	3.33	2.97	2.94	1.53
Price/Sales High	2.35	3.29	7.26	7.3	7.28	7.81	7.75	9.55	9.33	6.01	4.71	4.71	3.92	3.58	2.33
Price/Sales Low	1.06	1.67	1.88	4	4.97	4.98	5.35	3.9	3.57	2.4	3.15	2.55	2.01	1.94	1
Price/Cash Flow	12.58	12.5	21.36	14.96	14.28	29.4	19.25	13.9	19.79	49.27	61.45	97.76	-185.74	44.85	12.32
Price/Cash Flow Average	9.67	15.98	11.2	15.06	13.95	27.56	17.99	17.87	17.25	40.12	69.38	86.03	-200.48	65.2	15.4
Price/Cash Flow High	14.99	22.25	21.65	19.27	16.97	33.01	21.53	28.87	28.89	59.98	82.96	121.68	-265	79.35	23.54
Price/Cash Flow Low	6.73	11.31	5.6	10.57	11.57	21.06	14.87	11.8	11.07	23.96	55.4	65.89	-135.58	43.13	10.09
Price/Free Cash Flow Average	8.94	15.12	11.58	15.08	11.62	18.03	15.24	16.04	16.31	35.67	43.72	31.89	98.51	25.65	9.57
Price/Free Cash Flow High	13.86	21.06	22.4	19.3	14.14	21.6	18.24	25.91	27.32	53.33	52.28	45.1	130.21	31.21	14.62
Price/Free Cash Flow Low	6.22	10.71	5.79	10.59	9.64	13.78	12.6	10.59	10.47	21.3	34.91	24.42	66.61	16.96	6.26
EV/Sales Average	1.14	1.88	2.91	4.75	4.8	5.51	5.3	5.07	4.39	3.46	3.45	2.85	2.63	2.69	1.25
EV/Sales High	1.97	2.81	6.41	6.35	6.09	6.8	6.57	8.71	8.15	5.44	4.22	4.23	3.58	3.33	2.06
EV/Sales Low	0.68	1.19	1.03	3.05	3.78	3.97	4.18	3.06	2.4	1.84	2.65	2.07	1.67	1.7	0.72
EV/EBITDA Average	4.11	5.01	5.89	7.59	8.59	10.48	12.01	19.34	12.51	-448.99	-122.31	17.84	21.08	106.82	-26.51
EV/EBITDA High	7.12	7.48	12.98	10.13	10.91	12.93	14.9	33.23	23.22	-707.45	-149.69	26.49	28.74	132.12	-43.63
EV/EBITDA Low	2.44	3.17	2.09	4.87	6.77	7.56	9.47	11.68	6.83	-238.72	-94.1	12.95	13.37	67.33	-15.34
EV/EBIT Average	5.28	6.02	6.76	8.17	9.26	11.25	13.14	24.6	14.7	-31.16	-27.55	88.25	376.14	-63.24	-12.77
EV/EBIT High	9.16	9	14.9	10.91	11.77	13.88	16.3	42.26	27.28	-49.09	-33.72	131.08	512.83	-78.22	-21.01
EV/EBIT Low	3.14	3.81	2.4	5.25	7.3	8.11	10.36	14.86	8.02	-16.57	-21.2	64.05	238.64	-39.86	-7.39
Last Price	9.8	9.94	38.16	40.74	38.16	48.96	53.91	33.61	51.85	45.26	35.83	29.6	22.66	16.46	9.61
High Price	11.67	17.7	38.68	52.49	45.35	54.96	60.29	69.81	75.72	55.1	48.37	36.84	32.33	29.12	18.37
Enterprise Value Average	74	134	219	502	446	569	601	535	503	451	509	324	317	323	141
Enterprise Value High	128	200	482	670	567	703	745	919	934	710	623	481	433	399	232
Enterprise Value Low	44	85	78	322	351	411	474	323	275	240	392	235	201	203	82

Shares Outstanding	14	14	14	15	15	15	15	14	14	14	14	15	15	14	14
Diluted Weighted Avg Shares	14	14	15	15	15	15	15	15	14	14	15	15	15	15	14
Basic Weighted Avg Shares	13	13	14	15	15	15	15	14	14	14	14	15	15	15	14
Revenue per Share	4.96	5.38	5.33	7.19	6.23	7.04	7.78	7.31	8.12	9.17	10.26	7.82	8.24	8.14	7.87
EBITDA per Share	1.38	2.02	2.63	4.51	3.48	3.7	3.43	1.92	2.85	-0.07	-0.29	1.25	1.03	0.21	-0.37
Operating Income per Share	1.07	1.68	2.29	4.19	3.22	3.45	3.14	1.51	2.43	-1.02	-1.28	0.25	0.06	-0.35	-0.77
Basic EPS, GAAP	0.65	0.89	1.46	2.61	2.06	2.22	2.18	1.3	1.93	-1.69	0.29	-1.02	-5.64	-3.83	-0.76
Basic EPS from Cont Ops	0.65	0.89	1.46	2.61	2.06	2.22	2.18	1.3	1.93	-1.69	0.29	0.15	-0.23	-0.6	-0.7
Diluted EPS, GAAP	0.62	0.82	1.39	2.51	2.01	2.15	2.11	1.27	1.89	-1.69	0.28	-1.02	-5.64	-3.83	-0.76
Diluted EPS from Cont Ops	0.62	0.82	1.39	2.51	2.01	2.15	2.11	1.27	1.89	-1.69	0.28	0.15	-0.23	-0.6	-0.7
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.78	0.8	1.79	2.72	2.67	1.67	2.8	2.42	2.62	0.92	0.58	0.3	-0.12	0.37	0.78
Free Cash Flow per Basic Share	0.67	0.68	1.76	2.62	2.05	0.71	2.18	2.1	2.42	0.8	0.23	-0.21	-0.49	-0.2	0.3
Cash & Equivalents per Share	2.74	3.32	4.5	7.28	9.27	8.5	10.79	11.01	13.1	6.91	6.55	5.93	4.69	3.78	4.01
Book Value per Share	2.63	3.48	4.74	7.16	9.09	11.47	13.7	15.12	17.39	15.58	15.67	14.48	8.75	4.88	4.25
Tangible Book Value per Share	4.8	6	7.61	10.55	12.84	13.99	16.78	17.07	19.34	12.15	13.67	13.98	13.79	9.81	9.33

Anika Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)